Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials | Haematologica
A, Progression-free survival (PFS) and B, overall survival (OS) after... | Download Scientific Diagram
Kaplan-Meier curves of progression-free survival (PFS, | Open-i
OVERALL AND PROGRESSION-FREE SURVIVAL IN PATIENTS TREATED WITH.... EHA Library. Harrison C. Jun 9 2021; 324611
The Arts, Sciences and Medicine: Progression Free Survival (PFS)
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov | Journal of Clinical Oncology
PPT - PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE FOR OVERALL SURVIVAL ( OS) PowerPoint Presentation - ID:4160976
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Kaplan-Meier curves of progression-free survival (PFS) and overall... | Download Scientific Diagram
The value of progression-free survival to patients with advanced-stage cancer | Semantic Scholar
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD-1/PD-L1 Antibodies - ScienceDirect
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect